Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zicao ointment is a traditional Chinese topical herbal preparation primarily used for the treatment of burns and various skin conditions. Its main active ingredient is derived from the root of Lithospermum erythrorhizon (commonly known as Zi Cao or purple gromwell), which contains compounds such as shikonin and acetylshikonin with anti-inflammatory, wound-healing, and antimicrobial properties. Some formulations may also include other ingredients like Polistes mandarinus Saussure (a type of wasp extract). Zicao ointment has been shown in animal studies to promote healing in second-degree burns by reducing inflammation and enhancing granulation tissue formation. It is also commonly used for eczema, dermatitis, rashes, itching from insect bites, and general skin irritation. The mechanism involves anti-inflammatory effects on the skin as well as promotion of tissue regeneration[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zicao ointment.